Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 2,351,540	$ 2,538,758
Short term investments	2,902,105	7,399,636
Accounts receivable, trade, net of allowance for doubtful accounts of $0 at September 30, 2015 and December 31, 2014	792,274	901,623
Inventories	1,783,383	965,224
Prepaid expenses and other current assets	453,789	360,521
Total current assets	8,283,091	12,165,762
Property and equipment
Leasehold improvements	1,284,491	1,284,491
Furniture and computer equipment	535,768	476,788
Manufacturing and other equipment	1,017,262	972,386
Subtotal	2,837,521	2,733,665
Less: Accumulated depreciation	(1,333,608)	(1,078,060)
Net property and equipment	1,503,913	1,655,605
Internal use software	1,187,022	0
Intangible asset	2,215,385	2,215,385
Long term deposits	36,166	36,166
Total assets	13,225,577	16,072,918
Current liabilities
Accounts payable	978,279	474,662
Accrued expenses and other current liabilities	150,980	121,869
Accrued compensation	372,426	535,029
Deferred rent	130,216	130,216
Total current liabilities	1,631,901	1,261,776
Long term liabilities
Deferred rent, long term	809,275	874,825
Total liabilities	$ 2,441,176	$ 2,136,601
Commitments and Contingencies (Note 10)
Shareholders' equity
Common stock, $0.001 par value; 150,000,000 shares authorized, 12,172,715 and 12,084,859 shares issued and outstanding at September 30, 2015 and December 31, 2014	$ 12,172	$ 12,084
Additional paid-in capital	72,347,856	71,911,328
Accumulated other comprehensive loss	(601)	(6,448)
Accumulated deficit	(63,207,536)	(60,112,987)
Total BioLife Solutions, Inc. shareholders' equity	9,151,891	11,803,977
Total non-controlling interest equity	1,632,510	2,132,340
Total shareholders' equity	10,784,401	13,936,317
Total liabilities and shareholders' equity	$ 13,225,577	$ 16,072,918